Our "March Medication Madness" takes a structured look at the medications that consistently deliver in the LTC setting. These are the agents that balance efficacy with safety, align with geriatric best practices, and support stability across complex, chronic conditions.
In the list below, we identify the clinical "MVPs" by therapeutic category — medications that stand out based on evidence, tolerability, and practical use in long-term care populations.
Atorvastatin – A statin widely used for lowering cholesterol and reducing cardiovascular risk. Generally well-tolerated in older adults when monitored for muscle and liver effects.
Amlodipine – A calcium channel blocker effective for hypertension control, with a favorable safety profile in seniors and minimal risk of orthostatic hypotension.
Semaglutide – A GLP-1 receptor agonist that improves glycemic control and supports weight loss. Requires monitoring for gastrointestinal side effects, especially in frail older adults.
Acetaminophen – Recommended as first-line therapy for mild to moderate pain in older adults, while avoiding the gastrointestinal and renal risks associated with NSAIDs. Works great for arthritic pain when used consistently and avoid exceeding daily dose to prevent liver toxicity.
Amoxicillin – A broad-spectrum antibiotic suitable for many common infections, with dosing adjustments based on renal function in older patients.
Sertraline – An SSRI with a lower risk of anticholinergic effects and sedation compared to tricyclic antidepressants, making it a safer choice for depression and anxiety in seniors. Don't forget to monitor sodium levels in older adults.
Loratadine – A non-sedating antihistamine that avoids the anticholinergic burden of first-generation agents such as diphenhydramine.
Albuterol – A short-acting beta-agonist inhaler that provides rapid relief for asthma or COPD exacerbations, with minimal systemic effects when used correctly.
Pantoprazole – A proton pump inhibitor with fewer drug interactions than omeprazole. Recommended for the shortest effective duration to reduce risks such as bone loss and C. difficile infection. Use with some caution.
Erenumab – A monoclonal antibody that prevents migraines without the sedation or vascular risks associated with some older migraine treatments.
Etanercept – A biologic therapy for conditions such as rheumatoid arthritis and psoriasis, with a safety profile that can be favorable in certain older adults when infection risk is monitored. Use with some caution.
Quetiapine – Sometimes preferred in older adults when antipsychotic therapy is unavoidable, due to lower risk of extrapyramidal symptoms compared to typical antipsychotics. Should be used at the lowest effective dose, with close monitoring for sedation, orthostatic hypotension, metabolic effects, increased risk of falls, strokes, and mortality in dementia-related psychosis. Clinicians should always attempt Gradual Dose Reduction with antipsychotic use in elderly. Use with caution.
.jpg)
.jpg)
